Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets
Matej Ľupták, Danica Michaličková, Zdeněk Fišar, Eva Kitzlerová, Jana Hroudová
Abstract
agonists, D-amino acid oxidase inhibitors and cannabidiol. The use of anti-inflammatory agents as an add-on therapy is mentioned.
Topics & Concepts
Schizophrenia (object-oriented programming)DrugMedicinePharmacologyComputational biologyBioinformaticsPsychiatryBiologyTryptophan and brain disordersSchizophrenia research and treatmentBipolar Disorder and Treatment